Addiction

Arcadia Medicine Announces FDA Clearance of IND Application for a Patented Form of MDMA

SAN FRANCISCO, Oct. 06, 2025 (GLOBE NEWSWIRE) -- Arcadia Medicine (‘Arcadia’), a company developing safer empathogens to treat mental health…

3 months ago

Psilera Inc. Secures National Institutes of Health Grant for AUD Research

Small Business Innovation Research Grant will advance a novel neuroplastogen towards IND as potential treatment for Alcohol Use Disorder (AUD).…

3 months ago

SleepSpace Awarded NIH Grant to Transform Smartphones Into Digital Therapeutics for Insomnia, Cognition and Mental Health

SleepSpace Secures NIH Support to Pioneer the First Smartphone-Based Digital Therapeutic for Insomnia and Cognitive Health NEW YORK CITY, NEW…

3 months ago

New Study Confirms Recovery Connect App Improves Outcomes in Opioid Treatment

Community Medical Services Clinics saw up to 21% higher retention and patients linked to counselors through the app were 55%…

3 months ago

Transformed by His Promises Offers a 12-Week Journey to Emotional and Behavioral Freedom

Released in time for World Mental Health Day, "Transformed by His Promises" equips readers with clinically informed strategies and structured…

3 months ago

Spring Health Convenes AI in Mental Health Safety & Ethics Council to Set Industry Standards for Responsible AI

NEW YORK, Oct. 1, 2025 /PRNewswire/ -- Today, a coalition of leaders from academia, healthcare, technology, and employee benefits announced the…

3 months ago

MIRA Pharmaceuticals Closes Acquisition of SKNY Pharmaceuticals, Expands Pipeline with SKNY-1 for Obesity and Nicotine Addiction

Closing adds $5 million in marketable securities, strengthens financial position, and complements MIRA's advancing programs including Ketamir-2 and MIRA-55 MIAMI,…

3 months ago

Branded Legacy, Inc. Announces Provisional Patent Filing by BioLegacy for Disruptive Air-Driven Intranasal Platform Targeting Multi-Billion-Dollar Global Therapeutics Market

Revolutionary platform aims to make life-saving overdose reversal therapies more affordable, accessible, and effective worldwideVANCOUVER, British Columbia, Sept. 30, 2025…

3 months ago

Clearmind Medicine’s Convenes Inaugural Scientific Advisory Board Meeting to Advance Psychedelic-Derived Therapies

Vancouver, Canada, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

3 months ago

Shoreline Recovery Center Marks International Overdose Awareness Day, Honoring Families, First Responders, and Recovery Advocates

The Encinitas facility shines a light on families, first responders, and individuals in recovery while calling for education, compassion, and…

3 months ago